CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
Dexcom G4 or G5 Platinum CGM system +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02556554
NCT02556554N/ACompleted
CompareCT.gov

A Single-center, Prospective, 'Open-label,' Investigator-initiated Pilot Study Evaluating the Role of Continuous Glucose Monitor (CGM) Use Either Alone or With Remote Monitoring Capabilities in Pregnancy Associated With Type 1 Diabetes

University of Colorado, Denver·interventional·Posted Sep 22, 2015·Updated Jul 21, 2020

In Brief

A clinical study evaluating Dexcom G4 or G5 Platinum CGM system and Dexcom G4 or G5 Platinum CGM system with Share for Diabetes Mellitus, Type I. Completed, enrolled 67 participants across 1 site.

Detailed Summary

A single-center, prospective, 'open-label,' investigator-initiated pilot study evaluating the role of continuous glucose monitor (CGM) use either alone or with remote monitoring capabilities during pregnancy associated with T1DM.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type I
CountriesUnited States
CollaboratorsDexCom, Inc.

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 22, 2015
Enrollment StartAug 1, 2015
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 10.8 years ago

Interventions

Dexcom G4 or G5 Platinum CGM systemdevice

Intervention arm using the Dexcom G4 or G5 Platinum® CGM system during pregnancy

Dexcom G4 or G5 Platinum CGM system with Sharedevice

Treatment arm using the Dexcom G4 or G5 Platinum® CGM system with Share™